The D3 dopamine receptor in cellular and organismal function

被引:95
作者
Shafer, RA [1 ]
Levant, B [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA
关键词
limbic system; signal transduction; autoreceptor; receptor binding; behavior; locomotor activity; reward; development schizophrenia; Parkinson's disease; cocaine; antipsychotic;
D O I
10.1007/s002130050479
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The D-3 dopamine receptor is a member of the family of D-2-like dopamine receptors. Since the cloning and identification of the D-3 receptor in 1990, considerable progress has been made towards understanding the function of this novel site. Although some avenues of investigation have yielded more definitive results than others, studies to date indicate the D-3 receptor is localized preferentially in limbic brain areas and affects locomotion and perhaps reinforcement and reward. A subpopulation of the receptors appear to be autoreceptors which modulate dopamine synthesis, release, and neuronal activity. These observations have led to the hypothesis that the D-3 receptor may be an appropriate target in the treatment of neuropsychiatric disorders such as schizophrenia and drug addiction. The role of D-3 sites in disease, however, remains to be established. Genetic association of D-3 receptor polymorphisms with neuropsychiatric disorders have been proposed. Alterations in expression of Dg sites may occur in some diseases. Although the study of this receptor is clearly in the early stages, these findings lay the foundation for future investigation. In this review, dopamine D-3 receptor brain localization, cellular signaling mechanisms, and associated behavior will be discussed. The potential role of the D-3 site in neuropsychiatric disorders and as a therapeutic target is also addressed.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 201 条
  • [41] Di Bella D., 1994, Psychiatric Genetics, V4, P39
  • [42] DIAZ J, 1995, NEUROSCIENCE, V65, P731, DOI 10.1016/0306-4522(94)00527-C
  • [43] Homozygosity at the dopamine D3 receptor gene in schizophrenic patients
    Durany, N
    Thome, J
    Palomo, A
    Foley, P
    Riederer, P
    CruzSanchez, FF
    [J]. NEUROSCIENCE LETTERS, 1996, 220 (03) : 151 - 154
  • [44] Ebstein RP, 1997, AM J MED GENET, V74, P65, DOI 10.1002/(SICI)1096-8628(19970221)74:1<65::AID-AJMG15>3.0.CO
  • [45] 2-P
  • [46] Behavioural effects of the dopamine D-3 receptor agonist 7-OH-DPAT in rats
    Ferrari, F
    Giuliani, D
    [J]. PHARMACOLOGICAL RESEARCH, 1995, 32 (1-2) : 63 - 68
  • [47] FISHBURN CS, 1993, J BIOL CHEM, V268, P5872
  • [48] Early expression of D-3 dopamine receptors in murine embryonic development
    Fishburn, CS
    Bedford, M
    Lonai, P
    Fuchs, S
    [J]. FEBS LETTERS, 1996, 381 (03) : 257 - 261
  • [49] THE EFFECT OF HALOPERIDOL ON D2 DOPAMINE-RECEPTOR SUBTYPE MESSENGER-RNA LEVELS IN THE BRAIN
    FISHBURN, CS
    DAVID, C
    CARMON, S
    FUCHS, S
    [J]. FEBS LETTERS, 1994, 339 (1-2): : 63 - 66
  • [50] Flietstra R. J., 1996, Society for Neuroscience Abstracts, V22, P827